Logo image
Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse model
Journal article   Open access   Peer reviewed

Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse model

Li Jiang, Houbin Zhang, Alexander M. Dizhoor, Shannon E. Boye, William W. Hauswirth, Jeanne M. Frederick and Wolfgang Baehr
Proceedings of the National Academy of Sciences - PNAS, v 108(45), pp 18476-18481
08 Nov 2011
PMID: 22042849
url
https://europepmc.org/articles/pmc3215008View
Published, Version of Record (VoR)Open Access (License Unspecified) Open
url
https://doi.org/10.1073/pnas.1112758108View
Published, Version of Record (VoR) Open

Abstract

Biological Sciences
RNA interference (RNAi) gene silencing is a potential therapeutic strategy for dominant retinal degeneration disorders. We used self-complementary (sc) AAV2/8 vector to develop an RNAi-based gene therapy in a dominant retinal degeneration mouse model expressing bovine GCAP1(Y99C). We established an in vitro shRNA screening assay based on EGFP-tagged bovine GCAP1, and identified a shRNA that effectively silenced the bovine GCAP1 transgene with ∼80% efficiency. Subretinal injection of scAAV2/8 carrying shRNA expression cassette showed robust expression as early as 1 wk after injection. The gene silencing significantly improved photoreceptor survival, delayed disease onset, and increased visual function. Our results provide a promising strategy toward effective RNAi-based gene therapy by scAAV2/8 delivery for dominant retinal diseases.

Metrics

5 Record Views
42 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Biochemistry & Molecular Biology
Logo image